Description
INDICATIONS AND USAGE:
Imjudo (tremelimumab) is a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking antibody indicated only in combination with Imfinzi (durvalumab), for the treatment of adult patients with unresectable hepatocellular carcinoma (uHCC).
DOSAGE FORMS & STRENGTHS:
Injection: 300 mg/15 mL (20 mg/mL) solution in a single-dose vial.
Additional information
| Brand | Imjudo |
|---|---|
| Generic name | Tremelimumab infusion |
| Form | Parenteral |
| Strength | 300mg/15ml |
| Manufacturer | AstraZeneca |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
| Global delivery time | 10-20 days |
| Pay attention | Shipment should be organized from our Company with airlines only (Not FedEx, DHL, EMS, Aramex, UPS), at the specified storage condition along with one data logger. |
| Shipping type | Direct shipping/drop-shipping |
Related products
-
-
-
+ wishlist+ compare
Cidofovir injection, 375mg/5ml
Original price was: $1,391.00.$650.00Current price is: $650.00.Add to cart -
-
Reviews
There are no reviews yet.